Trial record 1 of 1 for:
NCT05456685
IMGN853 With Carboplatin in Second-line Treatment of FRα Expressing, Platinum-sensitive Epithelial Ovarian Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05456685 |
Recruitment Status :
Active, not recruiting
First Posted : July 13, 2022
Last Update Posted : May 1, 2024
|
Sponsor:
ImmunoGen, Inc.
Information provided by (Responsible Party):
ImmunoGen, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | June 30, 2025 |
Estimated Study Completion Date : | December 31, 2026 |